CXCL13 levels are elevated in patients with Waldenstrom macroglobulinemia, and are predictive of major response to ibrutinib

Josephine M. Vos; Nickolas Tsakmaklis; Christopher J. Patterson; Kirsten Meid; Jorge J. Castillo; Philip Brodsky; Tomas Ganz; Steven T. Pals; Marie José Kersten; Lian Xu; Guang Yang; Steven P. Treon; Zachary R. Hunter

doi:https://doi.org/10.3324/haematol.2017.172627

CXCL13 levels are elevated in patients with Waldenstrom macroglobulinemia, and are predictive of major response to ibrutinib

Josephine M. Vos, Nickolas Tsakmaklis, Christopher J. Patterson, Kirsten Meid, Jorge J. Castillo, Philip Brodsky, Tomas Ganz, Steven T. Pals, Marie José Kersten, Lian Xu, Guang Yang, Steven P. Treon, Zachary R. Hunter

Research output: Contribution to journal › Comment/Letter to the editor › Academic

19 Citations (Scopus)

Original language	English
Pages (from-to)	E452-E455
Journal	Haematologica
Volume	102
Issue number	11
Early online date	2017
DOIs	https://doi.org/10.3324/haematol.2017.172627
Publication status	Published - 2017

Access to Document

https://doi.org/10.3324/haematol.2017.172627

Cite this

Vos, J. M., Tsakmaklis, N., Patterson, C. J., Meid, K., Castillo, J. J., Brodsky, P., Ganz, T., Pals, S. T., Kersten, M. J., Xu, L., Yang, G., Treon, S. P., & Hunter, Z. R. (2017). CXCL13 levels are elevated in patients with Waldenstrom macroglobulinemia, and are predictive of major response to ibrutinib. Haematologica, 102(11), E452-E455. https://doi.org/10.3324/haematol.2017.172627

@article{a1adc5f422c642febc1d09ba9a993d45,

title = "CXCL13 levels are elevated in patients with Waldenstrom macroglobulinemia, and are predictive of major response to ibrutinib",

author = "Vos, {Josephine M.} and Nickolas Tsakmaklis and Patterson, {Christopher J.} and Kirsten Meid and Castillo, {Jorge J.} and Philip Brodsky and Tomas Ganz and Pals, {Steven T.} and Kersten, {Marie Jos{\'e}} and Lian Xu and Guang Yang and Treon, {Steven P.} and Hunter, {Zachary R.}",

year = "2017",

doi = "https://doi.org/10.3324/haematol.2017.172627",

language = "English",

volume = "102",

pages = "E452--E455",

journal = "Haematologica",

issn = "0390-6078",

publisher = "Ferrata Storti Foundation",

number = "11",

}

Vos, JM, Tsakmaklis, N, Patterson, CJ, Meid, K, Castillo, JJ, Brodsky, P, Ganz, T, Pals, ST , Kersten, MJ, Xu, L, Yang, G, Treon, SP & Hunter, ZR 2017, 'CXCL13 levels are elevated in patients with Waldenstrom macroglobulinemia, and are predictive of major response to ibrutinib', Haematologica, vol. 102, no. 11, pp. E452-E455. https://doi.org/10.3324/haematol.2017.172627

TY - JOUR

T1 - CXCL13 levels are elevated in patients with Waldenstrom macroglobulinemia, and are predictive of major response to ibrutinib

AU - Vos, Josephine M.

AU - Tsakmaklis, Nickolas

AU - Patterson, Christopher J.

AU - Meid, Kirsten

AU - Castillo, Jorge J.

AU - Brodsky, Philip

AU - Ganz, Tomas

AU - Pals, Steven T.

AU - Kersten, Marie José

AU - Xu, Lian

AU - Yang, Guang

AU - Treon, Steven P.

AU - Hunter, Zachary R.

PY - 2017

Y1 - 2017

U2 - https://doi.org/10.3324/haematol.2017.172627

DO - https://doi.org/10.3324/haematol.2017.172627

M3 - Comment/Letter to the editor

C2 - 28798070

SN - 0390-6078

VL - 102

SP - E452-E455

JO - Haematologica

JF - Haematologica

IS - 11

ER -